DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ppcwdd/north_america) has announced the addition of the "North America Genetic Testing Market Outlook to 2021" report to their offering.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the North America Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.
Key Topics Covered:
1 Tables & Figures
3 Genetic Testing Market, North America
4 Genetic Testing Market, Canada
5 Genetic Testing Market, Mexico
6 Genetic Testing Market, United States
7 Overview of Key Companies in North America Genetic Testing Market
8 Genetic Testing Market Pipeline Products
9 Financial Deals Landscape
10 Recent Developments
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare
- Danaher Corporation
- Abbott Laboratories
- Hologic, Inc.
- Qiagen N.V.
- Transgenomic, Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
For more information visit http://www.researchandmarkets.com/research/ppcwdd/north_america